157422
异戊酰氯
98%
别名:
3-甲基丁酰氯
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
(CH3)2CHCH2COCl
化学文摘社编号:
分子量:
120.58
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
203-552-2
Beilstein/REAXYS Number:
741910
MDL number:
Assay:
98%
产品名称
异戊酰氯, 98%
InChI
1S/C5H9ClO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3
InChI key
ISULZYQDGYXDFW-UHFFFAOYSA-N
SMILES string
CC(C)CC(Cl)=O
assay
98%
refractive index
n20/D 1.416 (lit.)
bp
115-117 °C (lit.)
density
0.989 g/mL at 25 °C (lit.)
functional group
acyl chloride
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
异戊酰氯被用于合成：
- furanodictines A和B
- 四肽酰胺，S-苄基-L-半胱氨酰-L-脯氨酰-L-亮氨酰甘氨酰胺
- (+)-blastmycinone
- (R)- 和(S)-2甲基-4-辛醇，某些甘蔗象鼻虫的聚集信息素
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Inhalation - Flam. Liq. 3 - Skin Corr. 1B
存储类别
3 - Flammable liquids
wgk
WGK 3
flash_point_f
87.8 °F - closed cup
flash_point_c
31 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
法规信息
危险化学品
此项目有
Organoaluminium induced ring-opening of epoxypyranosides. V. Formal total synthesis of antimycin A3 and synthesis of (+)-blastmycinone.
Inghardt T and Frejd T.
Tetrahedron, 47(32), 6483-6492 (1991)
Makoto Ogata et al.
Carbohydrate research, 345(2), 230-234 (2009-12-08)
A novel synthesis of furanodictines A [2-acetamido-3,6-anhydro-2-deoxy-5-O-isovaleryl-D-glucofuranose (1)] and B [2-acetamido-3,6-anhydro-2-deoxy-5-O-isovaleryl-D-mannofuranose (2)] is described starting from 2-acetamido-2-deoxy-D-glucose (GlcNAc). The synthetic protocol is based on deriving the epimeric bicyclic 3,6-anhydro sugars [2-acetamido-3,6-anhydro-2-deoxy-D-glucofuranose (4) and 2-acetamido-3,6-anhydro-2-deoxy-D-mannofuranose (5)] from GlcNAc. Reaction with borate
The Synthesis of the Tetrapeptide Amide S-Benzyl-L-cysteinyl-L-prolyl-L-leucylglycinamide
Ressler Cand Vincent du Vigneaud.
Journal of the American Chemical Society, 76(12), 3107-3109 (1954)
Enantioselective synthesis of (R)-and (S)-2-methyl-4-octanol, the male-produced aggregation pheromone of Curculionidae species.
Baraldi PT, et al.
Tetrahedron Asymmetry, 13(6), 621-624 (2002)
Jessica L Wojtaszek et al.
Cell, 178(1), 152-159 (2019-06-11)
Intrinsic and acquired drug resistance and induction of secondary malignancies limit successful chemotherapy. Because mutagenic translesion synthesis (TLS) contributes to chemoresistance as well as treatment-induced mutations, targeting TLS is an attractive avenue for improving chemotherapeutics. However, development of small molecules with
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持